HALOZYME THERAPEUTICS, INC. Quarterly Unrecognized Tax Benefits in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Halozyme Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2013 to Q4 2023.
  • Halozyme Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $21.9M, a 12.5% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $21.9M +$2.44M +12.5% Dec 31, 2023 10-K 2024-02-20
Q4 2022 $19.5M +$1.79M +10.1% Dec 31, 2022 10-K 2024-02-20
Q4 2021 $17.7M -$1.48M -7.7% Dec 31, 2021 10-K 2024-02-20
Q4 2020 $19.2M -$2.32M -10.8% Dec 31, 2020 10-K 2024-02-20
Q4 2019 $21.5M +$1.46M +7.27% Dec 31, 2019 10-K 2023-02-21
Q4 2018 $20M +$5.6M +38.8% Dec 31, 2018 10-K 2022-02-22
Q4 2017 $14.4M +$1.63M +12.7% Dec 31, 2017 10-K 2021-02-23
Q4 2016 $12.8M +$7.9M +161% Dec 31, 2016 10-K 2020-02-24
Q4 2015 $4.9M $0 0% Dec 31, 2015 10-K 2018-02-20
Q4 2014 $4.9M +$4.9M Dec 31, 2014 10-K 2019-02-21
Q4 2013 $0 Dec 31, 2013 10-K 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.